如果你的新分子实体没有明确的药物效应，请停止！
As a pharmacologist, I’ve always been curious about how drugs work. A favorite time-killer while…
Certara2023 年 8 月 18 日
Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases
Successful clinical development of new therapeutic interventions is notoriously difficult, especially in neurodegenerative diseases, where…
Certara2023 年 8 月 15 日
IRA impacts: First 10 drugs selected for the Drug Price Negotiation Program
The Inflation Reduction Act (enacted in August 2022) contains profound changes for the healthcare and…
Certara2023 年 8 月 15 日
Secondary Intelligence™: Empowering Decision-Making in Drug Development & Safety Assessment
Adverse effects of drugs pose potential harm to patients and can hinder or halt the…
Certara2023 年 8 月 11 日
Model-Informed Formulation Development: Insights from a Case Study
In a captivating webinar led by industry experts, Dr. Swati Jaiswal, Senior PBPK Consultant at…
Certara2023 年 8 月 10 日
Certara collaborates with Korea Institute of Toxicology to ensure FDA submission-ready SEND dataset
Software will aid optimizing pre-clinical data management in accordance with global standards and guidelines. Seoul,…
Certara2023 年 8 月 3 日
Drug Manufacturers’ Recent Drop in Insulin Prices in the United States
The prevalence of diabetes in the US is incredibly high and affects more than 10%…
Certara2023 年 8 月 3 日
价值传播如何决定你的商业成功？
Are you struggling to effectively communicate the value of your products or services in today's…
Certara2023 年 8 月 2 日
Certara and Drugs for Neglected Diseases initiative (DNDi) Partnering to Fast-track Data Submissions and Accelerate Drug Approvals for Neglected Patients
DNDi Utilizing Pinnacle 21 Enterprise (P21E), Certara’s Data Science platform for Biostatistics, Data Management, and…
Certara2023 年 7 月 31 日
